Sponsor pipeline

Iuliu Hatieganu University of Medicine and Pharmacy clinical trial pipeline

Get alerts when Iuliu Hatieganu University of Medicine and Pharmacy's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    Remimazolam Versus Propofol for Procedural Sedation in Gastrointestinal Endoscopy: A Single-Centre Prospective Observational Comparative Study in a High-Risk Population

    Phase changed: Phase 4 → not specified

    Also in this update: Trial completed; Study completion date changed from estimate of May 1, 2026 to Jun 1, 2026

    Iuliu Hatieganu University of Medicine and PharmacyNot specified NCT07362173 Registry history of NCT07362173 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-16 NCT07878858 Equivalence of Systolic Blood Pressure Measurements Between Fowler and Seated Positions Not Yet Recruiting

Active trials by phase

Phase 4
1
Not charted: 9 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Iuliu Hatieganu University of Medicine and Pharmacy's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free